Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 5461-5466

  Wu, Hao ^a   Liu, Qiang ^a   Cai, Tao ^a   Chen, Yu Dan ^a   Wang, Zhi Fei ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Chemosensitization; Glioblastoma; microRNA; Phytochemical; Signaling pathway

Indexed keywords

CURCUMIN; DIMETHYL SULFOXIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 146A; OLIGONUCLEOTIDE; PYRROLIDINE DITHIOCARBAMATE; SYNAPTOTAGMIN I; TEMOZOLOMIDE; ANTINEOPLASTIC AGENT; DACARBAZINE; MICRORNA; MIRN146 MICRORNA, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MTT ASSAY; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANALOGS AND DERIVATIVES; BRAIN TUMOR; DRUG EFFECTS; DRUG POTENTIATION; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84940554576     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4087     Document Type: Article

References (34)

1. Lwin Z, MacFadden D, Al-Zahrani A, Atenafu E, Miller BA, Sahgal A, Menard C, Laperriere N and Mason WP: Glioblastoma management in the temozolomide era: have we improved outcome? J Neurooncol 115: 303-310, 2013.
2. Julka PK, Sharma DN, Mallick S, Gandhi AK, Joshi N and Rath GK: Postoperative treatment of glioblastoma multiforme with radiation therapy plus concomitant and adjuvant temo-zolomide: A mono-institutional experience of 215 patients. J Cancer Res Ther 9: 381-386, 2013.
3. Alnaami IM, Al-Nuaimi SK, Senthilselvan A, Murtha AD, Walling S, Mehta V and Gourishankar S: Effectiveness of adjuvant temozolomide treatment in patients with glioblastoma. Neurosciences (Riyadh) 18: 349-355, 2013.
4. Bocangel DB, Finkelstein S, Schold SC, Bhakat KK, Mitra S and Kokkinakis DM: Multifaceted resistance of gliomas to temo-zolomide. Clin Cancer Res 8: 2725-2734, 2002.
5. Lavon I, Fuchs D, Zrihan D, Efroni G, Zelikovitch B, Fellig Y and Siegal T: Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O (6)-meth-ylguanine-DNA-methyltransferase. Cancer Res 67: 8952-8959, 2007.
6. Baldwin AS Jr: The NF-kappaB and I kappaB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
7. Mattioli I, Sebald A, Bucher C, et al: Transient and selective NF-kappaB p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappaB kinase beta and controls the kinetics of p65 nuclear import. J Immunol 172: 6336-6344, 2004.
8. Huang H, Lin H, Zhang X and Li J: Resveratrol reverses temo-zolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway. Oncol Rep 27: 2050-2056, 2012.
9. Gupta SC, Patchva S, Koh W and Aggarwal BB: Discovery of curcumin, a component of golden spice and its miraculous biological activities. Clin Exp Pharmacol Physiol 39: 283-299, 2012.
10. Shakibaei M, Mobasheri A, Lueders C, Busch F, Shayan P and Goel A: Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PLoS One 8: e57218, 2013.
11. Orr WS, Denbo JW, Saab KR, et al: Curcumin potentiates rhab-domyosarcoma radiosensitivity by suppressing NF-κB activity. PLoS One 8: e51309, 2013.
12. Dhandapani KM, Mahesh VB and Brann DW: Curcumin suppresses growth and chemoresistance of human glio-blastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102: 522-538, 2007.
13. Ramachandran C, Nair SM, Escalon E and Melnick SJ: Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force in brain tumor cell lines. J Complement Integr Med 9: Article 20, 2012.
14. Fabbri M: MicroRNAs and cancer: towards a personalized medicine. Curr Mol Med 13: 751-756, 2013.
15. Williams AE: Functional aspects of animal microRNAs. Cell Mol Life Sci 65: 545-562, 2008.
16. Sha M, Ye J, Zhang LX, Luan ZY and Chen YB: Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity. Cancer Cell Int 13: 50, 2013.
17. Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH and Friis-Hansen L: microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer 11: 71, 2012.
18. Bao B, Ali S, Banerjee S, et al: Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res 72: 335-345, 2012.
19. Park MH, Ahn BH, Hong YK and Min do S: Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways. Carcinogenesis 30: 356-365, 2009.
20. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 25: 402-408, 2001.
21. Agrawal DK and Mishra PK: Curcumin and its analogues: potential anticancer agents. Med Res Rev 30: 818-860, 2010.
22. Goel A and Aggarwal BB: Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 62: 919-930, 2010.
23. Chainani-Wu N: Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9: 161-168, 2003.
24. Zanotto-Filho A, Braganhol E, Edelweiss MI, et al: The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J Nutr Biochem 23: 591-601, 2012.
25. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB and Kondo Y: Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72: 29-39, 2007.
26. Koshkin PA, Chistiakov DA and Chekhonin VP: Role of microRNAs in mechanisms of glioblastoma resistance to radio-and chemotherapy. Biochemistry (Mosc) 78: 325-334, 2013.
27. Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li CH and Leung GK: MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells. Anticancer Res 32: 2835-2841, 2012.
28. Ujifuku K, Mitsutake N, Takakura S, et al: miR-195, miR-455-3p and miR-10a (∗) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett 296: 241-248, 2010.
29. Mei J, Bachoo R and Zhang CL: MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol 31: 3584-3592, 2011.
30. Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI and Kovalchuk O: Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 127: 1785-1794, 2010.
31. Atkinson GP, Nozell SE and Benveniste ET: NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 10: 575-586, 2010.
32. Fukushima T, Kawaguchi M, Yorita K, et al: Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma. Neuro Oncol 14: 19-28, 2012.
33. Brassesco MS, Roberto GM, Morales AG, et al: Inhibition of NF-κB by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and γ-radiation cytotoxicity in glioblastoma cells. Chemother Res Pract 2013: 593020, 2013.
34. Paik JH, Jang JY, Jeon YK, et al: MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res 17: 4761-4771, 2011.